EFFICACY OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT BY COMBINATION OF DENOSUMAB WITH PLAIN VITAMIN D OR WITH ANALOG OF VITAMIN D ALFACALCIDOL

被引：0
|
作者：
Pasalic, Katarina [1 ]
Novkovic, Snezana [2 ]
Gosic, Katarina [3 ]
Damjanov, Nemanja [4 ]
机构：
[1] Inst Rheumatol, Clin Rheumatol 6, Belgrade, Serbia
[2] Inst Rheumatol, Clin Rheumatol 3, Belgrade, Serbia
[3] Inst Rheumatol, Biochem Lab, Belgrade, Serbia
[4] Inst Rheumatol, Belgrade, Serbia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0499
引用
收藏
页码：944 / 944
页数：1
相关论文
共 50 条
  • [1] Comparison of the effects of denosumab between a native vitamin D combination and an active vitamin D combination in patients with postmenopausal osteoporosis
    Ebina, Kosuke
    Kashii, Masafumi
    Hirao, Makoto
    Hashimoto, Jun
    Noguchi, Takaaki
    Koizumi, Kota
    Kitaguchi, Kazuma
    Matsuoka, Hozo
    Iwahashi, Toru
    Tsukamoto, Yasunori
    Yoshikawa, Hideki
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2017, 35 (05) : 571 - 580
  • [2] Comparison of the effects of denosumab between a native vitamin D combination and an active vitamin D combination in patients with postmenopausal osteoporosis
    Kosuke Ebina
    Masafumi Kashii
    Makoto Hirao
    Jun Hashimoto
    Takaaki Noguchi
    Kota Koizumi
    Kazuma Kitaguchi
    Hozo Matsuoka
    Toru Iwahashi
    Yasunori Tsukamoto
    Hideki Yoshikawa
    [J]. Journal of Bone and Mineral Metabolism, 2017, 35 : 571 - 580
  • [3] VITAMIN D RECEPTOR GENE FOKI POLYMORPHISM AND THE EFFICACY OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT WITH DENOSUMAB
    Wawrzyniak, A.
    Krela-Kazmierczak, I.
    Marcinkowska, M.
    Kaczmarek-Rys, M.
    Michalak, M.
    Slomski, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S504 - S504
  • [4] Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol
    Ringe, JD
    Schacht, E
    [J]. RHEUMATOLOGY INTERNATIONAL, 2004, 24 (04) : 189 - 197
  • [5] Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol
    Johann D. Ringe
    Erich Schacht
    [J]. Rheumatology International, 2004, 24 : 189 - 197
  • [6] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
    Ringe, J. D.
    Farahmand, P.
    Schacht, E.
    Rozehnal, A.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 425 - 434
  • [7] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
    J. D. Ringe
    P. Farahmand
    E. Schacht
    A. Rozehnal
    [J]. Rheumatology International, 2007, 27 : 425 - 434
  • [8] The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis
    Shiraishi, A
    Higashi, S
    Ohkawa, H
    Kubodera, N
    Hirasawa, T
    Ezawa, I
    Ikeda, K
    Ogata, E
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1999, 65 (04) : 311 - 316
  • [9] Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis
    Ringe, JD
    Dorst, A
    Faber, H
    Schacht, E
    Rahlfs, VW
    [J]. RHEUMATOLOGY INTERNATIONAL, 2004, 24 (02) : 63 - 70
  • [10] Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?
    Francis, RM
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (01) : 111 - 114
12345